Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | CASP6 | P55212 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30449014 | 1.00 | AKR1B1 (1.00) | AKR1B1TDP1HSPA5TTRKDM4E | |
| SCHEMBL28714918 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| Potassium SCHEMBL4278025 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| SCHEMBL27558027 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| SCHEMBL4284420 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| Ammonia Solution, Strong SCHEMBL10886656 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| Phosphine SCHEMBL28850721 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| Hydrochloric Acid SCHEMBL8622012 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| SCHEMBL28407811 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E | |
| SCHEMBL28331403 | 0.98 | AKR1B1 (0.95) | AKR1B1TDP1HSPA5TTRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5130 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122059625-A | Mineral wool binder | 洛科威有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-4720665-A1 | METHOD OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | Molecular You Corporation (CA) | 2026-04-08 | — | — | EP | claimed |
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | SCRIPPS RESEARCH INST (US) | 2026-04-02 | — | — | US | claimed |
| EP-4704820-A1 | PHARMACEUTICALS CONTAINING CHELATORS WITH STRONG ZN IONS-HOLDING FEATURE FOR THE TREATMENT OF SYMPTOMS AND DISEASES CAUSED BY MICROORGANISMS/DISEASES CAUSED BY TOXINS OR NEUROTOXINS/CANCER/SEVERAL SYNDROMES | Huynh, Cong Nhan (VN) | 2026-03-11 | — | — | EP | claimed |
| EP-4695602-A1 | METHODS OF DETECTING OVER-IMMUNOSUPPRESSION AND UNDER- IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS | Olaris, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4416982-A | REACTING WITH PHENOLIC COMPOUND OR ANILINE COMPOUND IN THE PRESENCE OF PEROXIDASE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1983-11-22 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| US-4390723-A | BIS(8-QUINOLINOLATE) COPPER COMPLEX CATALYST | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-06-28 | — | — | US | claimed |
| EP-0025233-B1 | METHOD FOR PURIFICATION OF 6-(D-2-(D-2-AMINO-3-N-METHYLCARBAMOYLPROPIONAMIDO)-2-P-HYDROXYPHENYLACETAMIDO)-PENICILLANIC ACID | Tanabe Seiyaku Co., Ltd. (JP) | 1983-03-30 | — | — | EP | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| US-3966703-A | Asymmetrical frisazo dyestuffs derived from diazotized 2,7-diamino-carbazole | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | claimed |